← Leaderboards
Yuanyuan Chen
Case Western Reserve University
$2,842,773
Attributed
$2,842,773
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $459.3K · FY2015–25$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,842,773 · 4
By mechanism
R01$1,739,497 · 1
R00$711,096 · 1
P30$198,312 · 1
K99$193,868 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Paul S Park$7,385,674
- Robert Gerd Salomon$12,628,629
- Akiko Maeda$2,769,505
- Yoshikazu Imanishi$6,876,233
- Beata Jastrzebska$3,650,725
Others in their field
Top investigators on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Edward W Maly · United Nations Children'S Fund$264,005,699
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Everette D Joseph · Howard University$243,972,016
Research focus
VisionImageCell Culture TechniquesPharmaceutical PreparationsHigh Throughput ScreeningRetinaCellsMolecular ChaperonesMouse ModelPharmacological TreatmentKnock-In MouseMolecularInheritedBiochemicalLeadGenesCessation Of LifeMutantAffectEffective TherapyIn VitroIn VivoAcquired BlindnessMutation
Grant awards (12)
hIPSC-Reprogramming and Cell Culture Module$91,116
P30 · FY2025 · EY · contact PI
Pharmacological studies of rhodopsin metabolism$352,125
R01 · FY2024 · EY · contact PI
hIPSC-Reprogramming and Cell Culture Module$107,196
P30 · FY2024 · EY · contact PI
Pharmacological studies of rhodopsin metabolism$352,125
R01 · FY2023 · EY · contact PI
Pharmacological studies of rhodopsin metabolism$341,561
R01 · FY2022 · EY · contact PI
Pharmacological studies of rhodopsin metabolism$341,561
R01 · FY2021 · EY · contact PI
Pharmacological studies of rhodopsin metabolism$352,125
R01 · FY2020 · EY · contact PI
Drug discovery and mechanistic study of P23H rhodopsin associated retinitis pigmentosa$231,048
R00 · FY2019 · EY · contact PI
Drug discovery and mechanistic study of P23H rhodopsin associated retinitis pigmentosa$231,048
R00 · FY2018 · EY · contact PI
Drug discovery and mechanistic study of P23H rhodopsin associated retinitis pigmentosa$249,000
R00 · FY2017 · EY · contact PI
Drug discovery and mechanistic study of P23H rhodopsin associated retinitis pigmentosa$97,478
K99 · FY2016 · EY · contact PI
Drug discovery and mechanistic study of P23H rhodopsin associated retinitis pigmentosa$96,390
K99 · FY2015 · EY · contact PI